Hanwha Group

Hanwha Group is a major South Korean conglomerate that maintains a significant presence in the life sciences sector through its subsidiary, Hanwha Pharmaceuticals, and strategic investment arms. Hanwha Pharmaceuticals specializes in the development, manufacturing, and distribution of therapeutics for respiratory, cardiovascular, and digestive health, operating a major production facility in Yongin. Beyond traditional pharmaceuticals, the group has aggressively expanded into advanced biotechnology through Hanwha Impact, investing in cutting-edge fields such as gene writing, circular RNA, and synthetic biology. This dual approach combines a stable commercial pharmaceutical business with high-growth investments in next-generation medical technologies. The group also leverages its expertise in automation and robotics to support laboratory and manufacturing efficiencies within the healthcare industry. Hanwha continues to seek global partnerships to enhance its portfolio and reach in the international biotech market.